Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Community Resource Initiative (CRI) is a non-profit clinical research and service organization based in Boston, Massachusetts, specializing in HIV/AIDS and Hepatitis C. Since its inception in 1989, CRI has played a pivotal role in the development of numerous FDA-approved HIV medications through independent, community-based clinical trials. The organization bridges the gap between pharmaceutical innovation and patient care, particularly for underserved populations. Beyond research, CRI manages the Massachusetts HIV Drug Assistance Program (HDAP), ensuring access to life-saving treatments for thousands of individuals. Their work encompasses Phase 2 through Phase 4 clinical trials and public health advocacy, focusing on optimizing treatment outcomes and expanding healthcare access.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Community Resource Initiative.